Week 1: Diving in
I used this week at WCMC to get acquainted with my lab and start the clinical shadowing process. For the research component of my immersion term, I will be working with Ethel Cesarman in Experimental Pathology. Her research interests lie in lymphoma and Kaposi's sarcoma (KS). KS is a cancer that you have probably seen in movies and never fully recognized what it truly was. KS's is caused by the human herpes virus 8 (HHV8/KSHV), a virus that many of us are already infected with but show no symptoms, similar to the Epstein Barr virus. KSHV can usually be controlled by the immune system but in immunodeficient patients, malignant transformation occurs and sarcomas appear on the skin as dark, red, or white growths or patches. You have probably seen these in movies about the AIDS epidemic such as the photo of Matthew McConaughey below from the movie Dallas Buyers Club, although there are much more extreme cases in real life (picture from imbd.com) .
My role in this KSHV lab is to bring tissue engineering technology into research of KSHV viral infection models. Traditionally this research has been done with primary and immortalized cell lines, but that doesn't accurately represent the body. Therefore, my research project will be to engineer endothelial cell organoids that better recapitulate KSHV infection in the lymph nodes than cells in a dish. I will start by using my Cornell lab's lymphoma and lymph node organoids and tailor parameters for the primary human vein endothelial cells we plan to infect with KSHV.
In other news, this week I began shadowing Dr. Lisa Roth in the pediatric hematology and oncology clinic at NYP. She treats children with hematological malignancies including lymphoma and leukemia. I was able to see her interact with patients ranging in age from 3-19 years of age. The most interesting case that I saw was of a 18 year old male recovering from primary mediastinal B-cell lymphoma. This patient initially presented with an asymmetrical chest, with one side protruding much farther than the other. It turned out that he had a large lymphoma in the mediastinal region that showed invasion in the lungs, but he surprisingly didn't have any associated breathing problems. After treatment with combination chemotherapy (EPOCH) his mass had considerably reduced in size, although still showed activity on his most recent PET scan. Dr. Roth said that sometimes after chemotherapy, the immune system needs to reboot and produce all of the immune cells that were wiped out during treatment so the metabolic activity in the chest could just be the thymus doing its job and not cancer. I found it really interesting that there were no other follow up imaging studies to be done to further tell what was going on in this young man's chest. The doctor plans to watch this patient and have a followup PET scan in a couple of months to monitor the positive result, although she is hopeful that he is in the clear. I look forward to more shadowing with Dr. Roth, and hope that she can introduce me to some of her colleagues so that I can get some exposure to the treatment and monitoring of hematological malignancies in adults.
Comments
Post a Comment